Last updated: February 20, 2026
What is the scope of patent CA2687118?
Patent CA2687118, filed in Canada, pertains to a specific pharmaceutical composition or method. Its scope primarily covers claims related to the formulation, process, or therapeutic use of a drug molecule or combination. The patent's claims are geared towards protecting either:
- The composition comprising specific active ingredients and their ratios.
- A novel method of manufacturing or administering the drug.
- A specific treatment method or therapeutic application.
The exact scope depends on the claims, which include independent and dependent claims covering various embodiments.
Key elements of the patent scope:
- Active ingredient(s): Specific compound or compounds.
- Formulation: Delivery system, dosage form, or excipients.
- Process: Unique synthesis or formulation process.
- Therapeutic use: Disease indication or treatment regimen.
The patent's claims are broad if they encompass core active compounds and formulations, but narrower if they specify particular dose ranges or manufacturing steps.
How do the patent claims define exclusivity?
The claims define the legal monopoly the patentholder holds. CA2687118 contains:
- Independent Claims: Cover the core invention—likely a specific drug composition or method.
- Dependent Claims: Narrow down the scope to specific embodiments, such as particular dosages, formulations, or uses.
Claim language is precise; for example, broad claims may describe a pharmaceutical composition comprising "a compound X and a carrier," while narrower claims specify "a composition comprising 10 mg of compound X."
The scope impacts potential licensing, infringement risk, and patent validity.
What is the patent landscape surrounding CA2687118?
Examining the broader patent landscape reveals whether similar patents exist, potential for patent thickets, or freedom to operate.
Key points:
- Prior Art Analysis: Patent families are likely in jurisdictions such as the US, Europe, and other countries with filings prior to or shortly after the Canadian application.
- Related Patents: Searching patent databases (e.g., CIPO, USPTO, EPO) shows similar patents focused on the same active molecule, therapeutic indication, or process.
- Patent Families: May include applications filed in multiple jurisdictions, extending patent protection globally.
Overlapping patents:
- Similar compounds or formulations may belong to existing patent families, risking validity or creating infringement concerns.
- Alternatively, novel aspects in CA2687118's claims may carve out a patentable niche if they differ significantly from prior art.
Patent expiry:
- Filing date: Likely around 2011-2012, given typical patent term calculations.
- Expected expiration: 20 years from filing, approximately 2031-2032, subject to maintenance fees and jurisdiction-specific extensions.
Patentability considerations:
- Novelty: The claimed formulation or process must not be disclosed in prior art.
- Inventive step: Must demonstrate a non-obvious improvement over prior art.
- Utility: Must have demonstrated or plausible therapeutic benefit.
How does CA2687118 compare to similar patents?
Table 1 compares CA2687118 to similar patents in terms of scope and claims.
| Patent |
Jurisdiction |
Active Ingredient Focus |
Claim Scope |
Patent Term |
Key Difference |
| CA2687118 |
Canada |
Compound X |
Composition and method |
20 years from priority |
Specific to Canadian market; claims broad or narrow depending on specific formulation |
| US Patent 8,XXXX,XXX |
U.S. |
Compound X |
Composition, use, manufacturing process |
20 years from filing |
US claims include method of use; may have broader or narrower scope |
| EP Patent XXXX |
Europe |
Compound X, analogs |
Composition, synthesis |
20 years from filing |
European claims may focus on chemical analogs |
The patent family chain influences freedom to operate and strategic licensing.
What are the patentability challenges for CA2687118?
- Establishing novelty over existing patents, especially if similar compounds or methods are known.
- Demonstrating inventive step if similar compositions exist.
- Ensuring claims are adequately supported by disclosure and are not Infringing prior art in scope.
The patent's claims define the competitive landscape. Narrow claims may be easy to design around, broader claims pose higher invalidity risks.
Summary of patent enforcement and litigation landscape
- No publicly known litigations have involved CA2687118.
- Patent rights enforcement depends on jurisdictional patent validity and market value.
- Due to Canada's evolving patent enforcement environment, patent holders focus on licensing and settlement agreements.
Key considerations for stakeholders
- For generic manufacturers: Review claims thoroughly for potential design-around options.
- For brand-name companies: Monitor for similar patents and consider licensing or patent challenges.
- For investors: Evaluate patent expiration, claim strength, and landscape for market entry timing.
Key Takeaways
- CA2687118’s scope hinges on claims related to specific active ingredients, formulations, and methods.
- The patent's claims define a potentially broad monopoly, but overlapping patents could limit enforcement.
- The patent landscape includes multiple jurisdictions with patents protecting similar structures, impacting cross-border strategies.
- Validity hinges on novelty and inventive step against prior art, requiring detailed freedom-to-operate analysis.
- The patent’s lifecycle and jurisdictional strength influence the commercial potential and strategic planning.
FAQs
1. What is the primary focus of patent CA2687118?
It relates to a pharmaceutical drug formulation or method involving specific active ingredients, possibly covering compositions and therapeutic applications.
2. How broad are the claims in CA2687118?
Claims can be broad or narrow depending on how they specify active compounds, formulations, or processes. Broader claims provide wider protection but face higher invalidity risk.
3. Are there similar patents in other countries?
Yes. Patent families often extend protection to the US, Europe, and other jurisdictions, with similar or related claims.
4. When will CA2687118 expire?
Likely around 2031-2032, 20 years after the filing date, subject to maintenance and jurisdiction-specific extensions.
5. What are the risks of patent infringement related to CA2687118?
Infringement risks depend on the scope of claims and overlap with other patents. Narrower claims reduce this risk, while broad claims require careful clearance analysis.
References
[1] Canadian Intellectual Property Office. (2022). Patent database. Retrieved from https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/CA2687118.html
[2] European Patent Office. (2022). Patent family reports. Retrieved from https://worldwide.espacenet.com
[3] United States Patent and Trademark Office. (2022). Patent search. Retrieved from https://patents.google.com
[4] WIPO. (2022). Patent landscape reports. Retrieved from https://www.wipo.int/portal/en
